# reload+after+2024-01-22 06:44:09.148016
address1§2001 Market Street
address2§Suite 3915 Unit #15
city§Philadelphia
state§PA
zip§19103
country§United States
phone§267 225 7416
website§https://www.contexttherapeutics.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
fullTimeEmployees§9
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Martin A. Lehr', 'age': 39, 'title': 'Co-Founder, President, CEO & Director', 'yearBorn': 1984, 'fiscalYear': 2022, 'totalPay': 725250, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Jennifer  Minai-Azary', 'age': 45, 'title': 'CFO & Treasurer', 'yearBorn': 1978, 'fiscalYear': 2022, 'totalPay': 533655, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Alex C. Levit Esq.', 'age': 44, 'title': 'Chief Legal Officer & Corporate Secretary', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 512100, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Christopher  Beck M.B.A.', 'title': 'Senior Vice President of Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Tarek  Sahmoud M.D., Ph.D.', 'age': 62, 'title': 'Chief Medical Officer', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 26610, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§2.14
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§Context Therapeutics Inc.
longName§Context Therapeutics Inc.
firstTradeDateEpochUtc§1634736600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§9370db4d-3fc8-33de-8dd0-aba14eeca611
gmtOffSetMilliseconds§-18000000
recommendationMean§2.0
recommendationKey§buy
quickRatio§4.709
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
